Biocon Q4 results: Net profit grows 105% on strong biosimilar business growth

For the fiscal year 2020-21, Biocon reported a 1 per cent decline in net profit to Rs 740 crore; while revenue grew 14 per cent to Rs 7360 crore.

from Stocks-Markets-Economic Times https://ift.tt/3u2z3yl